TGFB1 Human Recombinant

Transforming Growth Factor-Beta 1 Human Recombinant
Cat. No.
BT2793
Source

CHO cells.

Synonyms
Transforming growth factor beta-1, TGF-beta-1, CED, DPD1, TGFB, TGF-b 1, LAP, TGFB1.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TGFB1 Human Recombinant produced in CHO cells is a glycosylated homodimeric polypeptide chain containing 2 x 112 amino acids and having a total molecular mass of 25.6kDa. The TGFB1 is purified by proprietary chromatographic techniques.

Product Specs

Introduction

Transforming growth factor betas (TGF-betas) are involved in cell-to-cell communication during embryonic development in mammals. There are three known types of TGF-betas: TGF-beta1, TGF-beta2, and TGF-beta3. All three TGF-betas are initially synthesized as larger precursor proteins. These precursor proteins undergo cleavage, resulting in a 112-amino acid polypeptide that remains connected to the inactive part of the molecule.

Description

Recombinant human TGFB1, produced in CHO cells, is a glycosylated homodimeric polypeptide chain consisting of 2 chains of 112 amino acids each. The total molecular weight of the protein is 25.6kDa. TGFB1 is purified using proprietary chromatographic methods.

Physical Appearance

The product appears as a sterile, filtered, white, lyophilized (freeze-dried) powder.

Formulation

The product is lyophilized from a sterile, filtered solution containing 0.1% trifluoroacetic acid (TFA) and trehalose at a protein-to-trehalose ratio of 1:20.

Solubility

To reconstitute the lyophilized TGFB1, it is recommended to dissolve it in sterile 10mM HCl at a concentration of 0.1 mg/ml. This solution can then be further diluted in other aqueous solutions as needed.

Stability

Lyophilized TGFB1, while stable at room temperature for up to 3 weeks, should be stored in a dry environment below -18°C. Once reconstituted, the human TGFB1 should be stored at 4°C for 2-7 days. For long-term storage, it is recommended to store it below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing cycles should be avoided.

Purity

The purity of the product is greater than 95.0% as assessed by SDS-PAGE analysis.

Biological Activity

The ED50, determined by the dose-dependent inhibition of IL-4-induced proliferation of HT-2 cells, is 0.0149 ng/ml. This corresponds to a specific activity of 6.7 x 10^7 units/mg.

Synonyms
Transforming growth factor beta-1, TGF-beta-1, CED, DPD1, TGFB, TGF-b 1, LAP, TGFB1.
Source

CHO cells.

Amino Acid Sequence
ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS.

Product Science Overview

Discovery and Biological Significance

TGF-β1 was originally identified for its ability to induce phenotypic transformation of fibroblasts . It is the most abundant isoform and is secreted by almost every cell type . TGF-β1 is involved in various physiological processes, including embryogenesis, tissue remodeling, and wound healing . It is secreted predominantly as latent complexes, which are stored at the cell surface and in the extracellular matrix . The release of biologically active TGF-β1 from a latent complex involves proteolytic processing of the complex and/or induction of conformational changes by proteins such as thrombospondin-1 .

Synthesis and Production

Human recombinant TGF-β1 is synthesized using genetic engineering techniques, enabling the production of large quantities of biologically active protein for research purposes . The recombinant form is typically derived from human embryonic kidney (HEK293) cells . The protein is a 25.0 kDa molecule with each subunit containing 112 amino acid residues, linked by a single disulfide bond . The recombinant TGF-β1 is purified to a high degree, with a purity of ≥ 98% as determined by SDS-PAGE gel and HPLC analyses .

Biological Activity and Applications

The biological activity of TGF-β1 is measured by its ability to inhibit the IL-4-dependent proliferation of mouse HT-2 cells . The effective dose (ED50) for this activity is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg . TGF-β1 has been implicated in various biological processes, including the formation of skin tumors . It is also involved in angiogenesis, immune regulation, and the promotion or inhibition of various immune events .

Research and Clinical Implications

Due to its wide range of biological activities, TGF-β1 is a subject of extensive research. It has been studied in the context of cancer, fibrosis, and immune disorders . The recombinant form of TGF-β1 is used in various research applications to study its effects on cell proliferation, differentiation, and immune modulation . It is also used in tissue engineering and regenerative medicine due to its role in tissue remodeling and wound healing .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.